Channel: Viral infections and Alzheimer's disease

None

2023 Articles

5 138 articles

SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model

  • Rubens Prince Dos Santos Alves, Ying-Ting Wang, Zbigniew Mikulski, …, Stephen Festin, Kenneth Kim, Sujan Shresta
  • Antiviral Res, 10.1016/j.antiviral.2023.105580
Comment Section

Editorial: Molecular and epigenetic mechanisms in neuroinflammation and neurodegeneration

  • Isaac Francos-Quijorna, Elisa Carrasco, Enrique Gabandé-Rodríguez, Isaac Francos-Quijorna, Elisa Carrasco, Enrique Gabandé-Rodríguez
  • None, 10.3389/fragi.2023.1271714
Comment Section

Full protection from SARS-CoV-2 brain infection and damage in susceptible transgenic mice conferred by MVA-CoV2-S vaccine candidate

  • Reposo Ramírez-Lorca, Roberto García-Swinburn, Daniel Cabello-Rivera, …, Mariano Esteban, José López-Barneo, Juan José Toledo-Aral
  • Nat Neurosci, 10.1038/s41593-022-01242-y
Comment Section

TREM2 is down-regulated by HSV1 in microglia and involved in antiviral defense in the brain

  • Stefanie Fruhwürth, Line S Reinert, Carl Öberg, …, Marcus Henricsson, Henrik Zetterberg, Søren R Paludan
  • Sci Adv, 10.1126/sciadv.adf5808
Comment Section

Animal Models for the Study of Neurologic Manifestations Of COVID-19

  • Kelsey C Carpenter, Jibing Yang, Jiajie Jessica Xu, …, Kelsey C Carpenter, Jibing Yang, Jiajie J Xu
  • Comp Med, 10.30802/aalas-cm-22-000073
Comment Section

SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC)

  • Amy D Proal, Michael B VanElzakker, Soo Aleman, …, Henry F VanBrocklin, Lael M Yonker, E John Wherry
  • Nat Immunol, 10.1038/s41590-023-01601-2
Comment Section

The viral hypothesis in Alzheimer’s disease: SARS-CoV-2 on the cusp

Comment Section

Host Genetic Variants Linked to COVID-19 Neurological Complications and Susceptibility in Young Adults-A Preliminary Analysis

  • Anastasiya Kazantseva, Renata Enikeeva, Zalina Takhirova, …, Alexandra Karunas, Alexander Kanapin, Elza Khusnutdinova
  • None, 10.3390/jpm13010123
Comment Section

Activated immune cells drive neurodegeneration in an Alzheimer’s model

  • Ian H Guldner, Tony Wyss-Coray, Ian H Guldner, …, Tony Wyss-Coray, Ian H Guldner, Tony Wyss-Coray
  • Nature, 10.1038/d41586-023-00600-5
Comment Section

2022 Articles

559 articles

Type I interferon signaling in SARS-CoV-2 associated neurocognitive disorder (SAND): Mapping host-virus interactions to an etiopathogenesis

  • George D Vavougios, Gabriel A de Erausquin, Heather M Snyder, …, George D Vavougios, Gabriel A de Erausquin, Heather M Snyder
  • None, 10.3389/fneur.2022.1063298
Comment Section

Alzheimer’s disease risk after COVID-19: a view from the perspective of the infectious hypothesis of neurodegeneration

  • Eugenia Olivera, Albany Sáez, Lila Carniglia, …, Carla Caruso, Mercedes Lasaga, Daniela Durand
  • None, 10.4103/1673-5374.360273
Comment Section

Increased protease-activated receptor 1 autoantibodies are associated with severe COVID-19

  • Florian Tran, Danielle M M Harris, Alena Scharmacher, …, Harald Heidecke, Gabriela Riemekasten, Stefan Schreiber
  • None, 10.1183/23120541.00379-2022
Comment Section

Spike protein receptor-binding domains from SARS-CoV-2 variants of interest bind human ACE2 more tightly than the prototype spike protein

  • Jermilia Charles, Nathan McCann, Victoria A Ploplis, …, Nathan McCann, Victoria A Ploplis, Francis J Castellino
  • Biochem Biophys Res Commun, 10.1016/j.bbrc.2022.12.011
Comment Section

Inborn errors of OAS-RNase L in SARS-CoV-2-related multisystem inflammatory syndrome in children

  • Danyel Lee, Jérémie Le Pen, Ahmad Yatim, …, Robert H Silverman, Shen-Ying Zhang, Jean-Laurent Casanova
  • Science, 10.1126/science.abo3627
Comment Section

Infection and chronic disease activate a brain-muscle signaling axis that regulates muscle performance

  • Shuo Yang, Meijie Tian, Yulong Dai, …, Wanbo Tai, Gong Cheng, Aaron Johnson
  • bioRxiv : the preprint server for biology, 10.1101/2020.12.20.423533
Comment Section

Characterizing Macrophages Diversity in COVID-19 Patients Using Deep Learning

  • Mario A Flores, Karla Paniagua, Wenjian Huang, …, Yidong Chen, Yufei Huang, Yufang Jin
  • Genes (Basel), 10.3390/genes13122264
Comment Section

Targeted screening of genetic associations with COVID-19 susceptibility and severity

Comment Section

CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID-19 therapy

  • Thiago Lazari Machado, Alanna Calheiros Santos, Tamiris Azamor, …, Livia M Villar, Ana P A Bom, Juliana G Melgaço
  • J Med Virol, 10.1002/jmv.28427
Comment Section

Brain autopsies of critically ill COVID-19 patients demonstrate heterogeneous profile of acute vascular injury, inflammation and age-linked chronic brain diseases

  • Jose M Farfel, Konstantinos Arfanakis, Lena Al-Harthi, …, David A Bennett, Rupal Mehta, Julie A Schneider
  • Acta Neuropathol Commun, 10.1186/s40478-022-01493-7
Comment Section